Leadership, Planning and Evaluation
领导、规划和评估
基本信息
- 批准号:9789591
- 负责人:
- 金额:$ 15.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-10 至
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdvisory CommitteesBasic ScienceCancer Center Support GrantCatchment AreaClinicalClinical ResearchClinical SciencesCommunity OutreachComprehensive Cancer CenterCounselingDecision MakingEnvironmentEvaluationFeedbackFundingFunding OpportunitiesGoalsGrowthLeadershipMissionPhysiciansPopulation SciencesQuality of CareRecommendationResearchResource SharingReview CommitteeServicesStrategic PlanningTimeLineTraining ActivityTraining and EducationTranslational ResearchUniversitiesVisionanticancer researchcancer educationexperiencehigh standardmemberoncology servicepopulation basedprogramssuccess
项目摘要
PROJECT SUMMARY: LEADERSHIP, PLANNING, AND EVALUATION
Stephen D. Nimer, MD, was appointed as Sylvester Comprehensive Cancer Center (Sylvester) Director in 2012.
Under his leadership, Sylvester has experienced exponential growth, driven by its dedicated leadership team,
its highly engaged and experienced External Advisory Board (EAB), its productive relationship with University
leadership, and its adherence to a carefully constructed 2014-2018 Strategic Plan with clear standards,
timelines, goals, and deliverables. Nimer leads Sylvester with the assistance of a senior leadership team
comprised of a Deputy Director, six Associate Directors, an Associate Vice President, and Physician-in-Chief
for the Oncology Service Line. Collectively, this team provides thoughtful and important counsel to the Director,
including strategies that promote the growth of Sylvester’s basic, translational, clinical, and population science
research portfolio; education and training activities; community outreach and engagement capabilities; shared
resource support; and its ability to define new research directions and create new programs and funding
opportunities for its members. In addition to the guidance offered by Sylvester’s robust senior leadership team,
Sylvester has seven internal review committees that provide recommendations and oversee the
implementation of Sylvester’s activities and strategic plans; including the Executive Committee, Space
Allocation, Intramural Funding Program (IFP), Scientific Steering Committee (SSC), Clinical Research Internal
Advisory Board (CRIAB), Cancer Education Leadership Council (CELC), and Community Outreach and
Engagement Internal Advisory Board (COE IAB). Additionally, two external advisory entities—the External
Advisory Board (EAB) and the Board of Overseers (BOO)—provide advice and expertise that is critical to
Sylvester’s success. Supplementing Sylvester’s senior leadership and internal and external advisory
committees are the many planning and evaluation efforts (e.g. Shared Resource Advisory Groups (SR AG)
and Membership), which are presented for consideration and action to the Scientific Steering and Executive
Committees. In aggregate, feedback from these advisory entities allows Sylvester to obtain effective internal
and external advice, set priorities, make decisions, and define and evaluate the Center’s strategic plans and
activities. These activities drive Sylvester’s mission and vision maximizing the Center’s ability to advance a full
cancer research agenda, maintain the highest standard/quality of care and research, and serve its unique
catchment area, one with unparalleled diversity.
项目总结:领导、规划和评估
斯蒂芬·D·尼默,医学博士,2012年被任命为西尔维斯特综合癌症中心(西尔维斯特)主任。
在他的领导下,西尔维斯特经历了指数级的增长,在其敬业的领导团队的推动下,
它高度参与和经验丰富的外部顾问委员会(EAB),它与大学的富有成效的关系
领导力,以及遵守精心制定的具有明确标准的2014-2018年战略计划,
时间表、目标和可交付成果。尼默在高级领导团队的协助下领导西尔维斯特
由1名副主任、6名副主任、1名副会长和主任医师组成
肿瘤学服务专线。总体而言,这个团队为署长提供了深思熟虑和重要的咨询意见,
包括促进西尔维斯特的基础科学、翻译科学、临床科学和人口科学发展的战略
研究组合;教育和培训活动;社区推广和参与能力;共享
资源支持;以及确定新的研究方向和创建新的计划和资金的能力
为其成员提供机会。除了西尔维斯特强大的高级领导团队提供的指导外,
西尔维斯特有七个内部审查委员会,它们提供建议并监督
执行西尔维斯特的活动和战略计划;包括空间执行委员会
拨款、内部资助计划(IFP)、科学指导委员会(SSC)、临床研究内部
咨询委员会(CRIAB)、癌症教育领导委员会(CELC)、社区外展和
接洽内部咨询委员会(COE IAB)。此外,两个外部咨询实体--外部
咨询委员会(EAB)和监督委员会(BOO)-提供对以下方面至关重要的建议和专业知识
西尔维斯特的成功。补充西尔维斯特的高级领导和内部和外部咨询
委员会是许多规划和评估工作(例如共享资源咨询小组(SR AG))
和成员),提交给科学指导和执行委员会审议和采取行动
委员会。总的来说,来自这些咨询实体的反馈使西尔维斯特能够获得有效的内部
和外部建议,设定优先事项,作出决策,并定义和评估中心的战略计划和
活动。这些活动推动了西尔维斯特的使命和愿景,最大限度地提高了中心推进全面
癌症研究议程,保持最高标准/质量的护理和研究,并为其独特的
集水区,一个具有无与伦比的多样性的地区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen D. Nimer其他文献
Destabilization of AETFC through C/EBPα-mediated repression of LYL1 contributes to t(8;21) leukemic cell differentiation
通过 C/EBPα 介导的 LYL1 抑制导致 AETFC 不稳定,有助于 t(8;21) 白血病细胞分化
- DOI:
10.1038/s41375-019-0398-8 - 发表时间:
2019-02-12 - 期刊:
- 影响因子:13.400
- 作者:
Meng-Meng Zhang;Na Liu;Yuan-Liang Zhang;Bowen Rong;Xiao-Lin Wang;Chun-Hui Xu;Yin-Yin Xie;Shuhong Shen;Jiang Zhu;Stephen D. Nimer;Zhu Chen;Sai-Juan Chen;Robert G. Roeder;Fei Lan;Lan Wang;Qiu-Hua Huang;Xiao-Jian Sun - 通讯作者:
Xiao-Jian Sun
Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression.
人粒细胞巨噬细胞集落刺激因子 (GM-CSF):表达调节。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Judy C. Gasson;J. Fraser;Stephen D. Nimer - 通讯作者:
Stephen D. Nimer
Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects.
重组人促红细胞生成素和肾性贫血:分子生物学、临床疗效和神经系统影响。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:39.2
- 作者:
Allen R. Nissenson;Stephen D. Nimer;Deane L. Wolcott - 通讯作者:
Deane L. Wolcott
TAF1, the Largest Subunit of Tfiid, Is Dispensable for Adult Hematopoiesis
- DOI:
10.1182/blood-2023-187166 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Fan Liu;Jingyin Yue;Francesco Tamiro;Jun Sun;Pradeepkumar Reddy Cingaram;Krystal Lisa Hossack;Concepcion Martinza Caja;Felipe Beckedorff;Ramin Shiekhattar;Stephen D. Nimer - 通讯作者:
Stephen D. Nimer
The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia.
IL-3、SCF、IL-6 和 IL-11 治疗血小板减少症的功效。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Peter Maslak;Stephen D. Nimer - 通讯作者:
Stephen D. Nimer
Stephen D. Nimer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen D. Nimer', 18)}}的其他基金
The Impact of Perioperative Opioids on the Gut Estrobolome in Breast Cancer Patients
围手术期阿片类药物对乳腺癌患者肠道雌激素的影响
- 批准号:
10752298 - 财政年份:2019
- 资助金额:
$ 15.24万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 15.24万 - 项目类别:
Standard Grant